MRK logo

Merck & Co (MRK) Net income

annual net income:

$17.12B+$16.75B(+4589.59%)
December 1, 2024

Summary

  • As of today (April 12, 2025), MRK annual net profit is $17.12 billion, with the most recent change of +$16.75 billion (+4589.59%) on December 1, 2024.
  • During the last 3 years, MRK annual net income has risen by +$4.07 billion (+31.17%).
  • MRK annual net income is now at all-time high.

Performance

MRK Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

quarterly net income:

$3.74B+$586.00M(+18.56%)
December 1, 2024

Summary

  • As of today (April 12, 2025), MRK quarterly net profit is $3.74 billion, with the most recent change of +$586.00 million (+18.56%) on December 1, 2024.
  • Over the past year, MRK quarterly net income has stayed the same.
  • MRK quarterly net income is now -48.84% below its all-time high of $7.32 billion, reached on December 31, 2014.

Performance

MRK quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

TTM net income:

$17.12B+$4.97B(+40.90%)
December 1, 2024

Summary

  • As of today (April 12, 2025), MRK TTM net profit is $17.12 billion, with the most recent change of +$4.97 billion (+40.90%) on December 1, 2024.
  • Over the past year, MRK TTM net income has stayed the same.
  • MRK TTM net income is now at all-time high.

Performance

MRK TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

MRK Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4589.6%0.0%0.0%
3 y3 years+31.2%0.0%0.0%
5 y5 years+73.9%0.0%0.0%

MRK Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+4589.6%-31.4%+162.6%at high+4589.6%
5 y5-yearat high+4589.6%-31.4%+162.6%at high+4589.6%
alltimeall timeat high+4589.6%-48.8%+162.6%at high>+9999.0%

Merck & Co Net income History

DateAnnualQuarterlyTTM
Dec 2024
$17.12B(+4589.6%)
$3.74B(+18.6%)
$17.12B(+40.9%)
Sep 2024
-
$3.16B(-42.1%)
$12.15B(-11.6%)
Jun 2024
-
$5.46B(+14.6%)
$13.74B(+495.7%)
Mar 2024
-
$4.76B(-488.4%)
$2.31B(+531.8%)
Dec 2023
$365.00M(-97.5%)
-$1.23B(-125.8%)
$365.00M(-92.1%)
Sep 2023
-
$4.75B(-179.4%)
$4.61B(+48.1%)
Jun 2023
-
-$5.97B(-311.8%)
$3.11B(-76.1%)
Mar 2023
-
$2.82B(-6.5%)
$13.03B(-10.3%)
Dec 2022
$14.52B(+11.3%)
$3.02B(-7.1%)
$14.52B(-4.9%)
Sep 2022
-
$3.25B(-17.6%)
$15.26B(-8.0%)
Jun 2022
-
$3.94B(-8.5%)
$16.58B(+16.9%)
Mar 2022
-
$4.31B(+14.7%)
$14.18B(+8.7%)
Dec 2021
$13.05B(+84.6%)
$3.76B(-17.7%)
$13.05B(+81.3%)
Sep 2021
-
$4.57B(+195.6%)
$7.20B(+29.2%)
Jun 2021
-
$1.54B(-51.4%)
$5.57B(-20.7%)
Mar 2021
-
$3.18B(-251.8%)
$7.03B(-0.6%)
Dec 2020
$7.07B(-28.2%)
-$2.09B(-171.2%)
$7.07B(-38.6%)
Sep 2020
-
$2.94B(-2.0%)
$11.52B(+9.9%)
Jun 2020
-
$3.00B(-6.7%)
$10.48B(+3.3%)
Mar 2020
-
$3.22B(+36.6%)
$10.15B(+3.1%)
Dec 2019
$9.84B(+58.2%)
$2.36B(+23.9%)
$9.84B(+5.7%)
Sep 2019
-
$1.90B(-28.8%)
$9.31B(-0.5%)
Jun 2019
-
$2.67B(-8.4%)
$9.36B(+11.5%)
Mar 2019
-
$2.92B(+59.6%)
$8.40B(+35.0%)
Dec 2018
$6.22B(+159.8%)
$1.83B(-6.3%)
$6.22B(+85.8%)
Sep 2018
-
$1.95B(+14.2%)
$3.35B(+149.6%)
Jun 2018
-
$1.71B(+131.9%)
$1.34B(-15.1%)
Mar 2018
-
$736.00M(-170.4%)
$1.58B(-34.0%)
Dec 2017
$2.39B(-38.9%)
-$1.05B(+1767.9%)
$2.40B(-15.8%)
Sep 2017
-
-$56.00M(-102.9%)
$2.85B(-44.0%)
Jun 2017
-
$1.95B(+25.5%)
$5.09B(+17.1%)
Mar 2017
-
$1.55B(-360.7%)
$4.34B(+10.9%)
Dec 2016
$3.92B(-11.8%)
-$595.00M(-127.2%)
$3.92B(-28.6%)
Sep 2016
-
$2.18B(+81.2%)
$5.49B(+7.0%)
Jun 2016
-
$1.21B(+7.1%)
$5.13B(+11.2%)
Mar 2016
-
$1.13B(+15.1%)
$4.62B(+3.9%)
Dec 2015
$4.44B(-62.7%)
$977.00M(-46.5%)
$4.44B(-58.8%)
Sep 2015
-
$1.83B(+165.8%)
$10.78B(+9.5%)
Jun 2015
-
$687.00M(-27.9%)
$9.85B(-11.8%)
Mar 2015
-
$953.00M(-87.0%)
$11.17B(-6.3%)
Dec 2014
$11.92B(+170.7%)
$7.32B(+717.4%)
$11.92B(+121.4%)
Sep 2014
-
$895.00M(-55.3%)
$5.38B(-4.1%)
Jun 2014
-
$2.00B(+17.5%)
$5.61B(+24.3%)
Mar 2014
-
$1.71B(+118.3%)
$4.52B(+2.5%)
Dec 2013
$4.40B(-28.6%)
$781.00M(-30.5%)
$4.40B(-2.8%)
Sep 2013
-
$1.12B(+24.1%)
$4.53B(-11.8%)
Jun 2013
-
$906.00M(-43.1%)
$5.13B(-14.7%)
Mar 2013
-
$1.59B(+75.6%)
$6.02B(-2.4%)
Dec 2012
$6.17B(-1.7%)
$907.00M(-47.5%)
$6.17B(-8.9%)
Sep 2012
-
$1.73B(-3.6%)
$6.77B(+0.5%)
Jun 2012
-
$1.79B(+3.2%)
$6.74B(-3.3%)
Mar 2012
-
$1.74B(+14.9%)
$6.97B(+11.1%)
Dec 2011
$6.27B(+628.5%)
$1.51B(-10.6%)
$6.27B(+48.4%)
Sep 2011
-
$1.69B(-16.4%)
$4.23B(+46.9%)
Jun 2011
-
$2.02B(+94.1%)
$2.88B(+79.3%)
Mar 2011
-
$1.04B(-296.1%)
$1.60B(+86.4%)
Dec 2010
$861.00M(-93.3%)
-$532.00M(-255.6%)
$861.00M(-89.1%)
Sep 2010
-
$342.00M(-54.5%)
$7.89B(-28.1%)
Jun 2010
-
$752.00M(+151.5%)
$10.97B(-6.8%)
Mar 2010
-
$299.00M(-95.4%)
$11.77B(-8.7%)
Dec 2009
$12.90B(+65.2%)
$6.49B(+89.6%)
$12.90B(+60.2%)
Sep 2009
-
$3.42B(+120.0%)
$8.05B(+40.8%)
Jun 2009
-
$1.56B(+9.2%)
$5.72B(-3.6%)
Mar 2009
-
$1.43B(-13.3%)
$5.93B(-24.0%)
Dec 2008
$7.81B(+138.4%)
$1.64B(+50.5%)
$7.81B(+72.3%)
Sep 2008
-
$1.09B(-38.2%)
$4.53B(-8.7%)
Jun 2008
-
$1.77B(-46.5%)
$4.97B(+1.9%)
Mar 2008
-
$3.30B(-302.5%)
$4.87B(+48.8%)
Dec 2007
$3.28B(-26.1%)
-$1.63B(-206.9%)
$3.28B(-39.1%)
Sep 2007
-
$1.53B(-9.0%)
$5.38B(+12.2%)
Jun 2007
-
$1.68B(-1.6%)
$4.80B(+3.8%)
Mar 2007
-
$1.70B(+259.6%)
$4.62B(+4.2%)
Dec 2006
$4.43B(-4.3%)
$473.90M(-49.6%)
$4.43B(-12.7%)
Sep 2006
-
$940.60M(-37.3%)
$5.08B(-8.6%)
Jun 2006
-
$1.50B(-1.4%)
$5.56B(+16.3%)
Mar 2006
-
$1.52B(+35.8%)
$4.78B(+3.2%)
Dec 2005
$4.63B(-20.6%)
$1.12B(-21.2%)
$4.63B(+0.0%)
Sep 2005
-
$1.42B(+97.2%)
$4.63B(+2.1%)
Jun 2005
-
$720.60M(-47.4%)
$4.53B(-18.8%)
Mar 2005
-
$1.37B(+22.6%)
$5.58B(-4.3%)
Dec 2004
$5.83B
$1.12B(-15.7%)
$5.83B(-4.5%)
Sep 2004
-
$1.33B(-25.0%)
$6.11B(-8.0%)
DateAnnualQuarterlyTTM
Jun 2004
-
$1.77B(+9.2%)
$6.64B(-1.5%)
Mar 2004
-
$1.62B(+16.0%)
$6.74B(-1.3%)
Dec 2003
$6.83B(-4.5%)
$1.40B(-24.9%)
$6.83B(-6.8%)
Sep 2003
-
$1.86B(-0.5%)
$7.33B(-0.3%)
Jun 2003
-
$1.87B(+9.2%)
$7.35B(+1.6%)
Mar 2003
-
$1.71B(-9.5%)
$7.23B(+1.2%)
Dec 2002
$7.15B(-1.8%)
$1.89B(+0.3%)
$7.15B(+0.4%)
Sep 2002
-
$1.88B(+7.6%)
$7.12B(-0.9%)
Jun 2002
-
$1.75B(+7.7%)
$7.18B(-0.9%)
Mar 2002
-
$1.63B(-12.7%)
$7.25B(-0.4%)
Dec 2001
$7.28B(+6.7%)
$1.86B(-4.5%)
$7.28B(+1.3%)
Sep 2001
-
$1.95B(+7.3%)
$7.19B(+1.6%)
Jun 2001
-
$1.82B(+9.5%)
$7.07B(+1.3%)
Mar 2001
-
$1.66B(-6.1%)
$6.98B(+2.3%)
Dec 2000
$6.82B(+15.8%)
$1.76B(-3.9%)
$6.82B(+2.9%)
Sep 2000
-
$1.84B(+6.6%)
$6.63B(+4.7%)
Jun 2000
-
$1.72B(+14.8%)
$6.33B(+4.0%)
Mar 2000
-
$1.50B(-4.7%)
$6.09B(+3.4%)
Dec 1999
$5.89B(+12.2%)
$1.57B(+2.2%)
$5.89B(+3.0%)
Sep 1999
-
$1.54B(+4.2%)
$5.72B(+3.1%)
Jun 1999
-
$1.48B(+13.7%)
$5.55B(+3.0%)
Mar 1999
-
$1.30B(-7.2%)
$5.38B(+2.6%)
Dec 1998
$5.25B(+13.7%)
$1.40B(+2.5%)
$5.25B(+3.1%)
Sep 1998
-
$1.37B(+3.9%)
$5.09B(+3.5%)
Jun 1998
-
$1.32B(+13.0%)
$4.92B(+3.4%)
Mar 1998
-
$1.16B(-6.3%)
$4.76B(+3.1%)
Dec 1997
$4.61B(+18.9%)
$1.24B(+3.8%)
$4.61B(+4.5%)
Sep 1997
-
$1.20B(+3.7%)
$4.42B(+4.6%)
Jun 1997
-
$1.15B(+13.1%)
$4.22B(+4.5%)
Mar 1997
-
$1.02B(-2.2%)
$4.04B(+4.0%)
Dec 1996
$3.88B(+16.4%)
$1.04B(+4.2%)
$3.88B(+5.0%)
Sep 1996
-
$1.00B(+3.1%)
$3.70B(+3.9%)
Jun 1996
-
$972.10M(+12.5%)
$3.56B(+3.3%)
Mar 1996
-
$863.80M(+0.7%)
$3.44B(+3.2%)
Dec 1995
$3.34B(+11.3%)
$857.80M(-0.5%)
$3.34B(+2.6%)
Sep 1995
-
$861.90M(+0.4%)
$3.25B(+2.4%)
Jun 1995
-
$858.10M(+13.3%)
$3.17B(+3.1%)
Mar 1995
-
$757.40M(-2.0%)
$3.08B(+2.7%)
Dec 1994
$3.00B(+38.4%)
$772.90M(-1.5%)
$3.00B(+3.4%)
Sep 1994
-
$784.80M(+2.7%)
$2.90B(+2.8%)
Jun 1994
-
$764.10M(+13.2%)
$2.82B(+26.6%)
Mar 1994
-
$675.20M(+0.1%)
$2.23B(+2.8%)
Dec 1993
$2.17B(+9.2%)
$674.20M(-4.5%)
$2.17B(+34.6%)
Sep 1993
-
$705.70M(+308.9%)
$1.61B(+4.0%)
Jun 1993
-
$172.60M(-71.9%)
$1.55B(-23.7%)
Mar 1993
-
$613.80M(+421.9%)
$2.03B(+2.3%)
Dec 1992
$1.98B(-6.5%)
$117.60M(-81.8%)
$1.98B(-17.2%)
Sep 1992
-
$644.50M(-1.4%)
$2.40B(+4.0%)
Jun 1992
-
$653.40M(+14.9%)
$2.30B(+4.4%)
Mar 1992
-
$568.70M(+7.3%)
$2.21B(+4.0%)
Dec 1991
$2.12B(+19.1%)
$529.80M(-4.1%)
$2.12B(+4.3%)
Sep 1991
-
$552.40M(-0.6%)
$2.03B(+4.5%)
Jun 1991
-
$556.00M(+15.0%)
$1.95B(+4.6%)
Mar 1991
-
$483.50M(+9.3%)
$1.86B(+4.5%)
Dec 1990
$1.78B(+19.1%)
$442.20M(-4.9%)
$1.78B(+4.4%)
Sep 1990
-
$465.00M(-1.1%)
$1.71B(+4.6%)
Jun 1990
-
$470.20M(+16.4%)
$1.63B(+4.7%)
Mar 1990
-
$403.80M(+9.8%)
$1.56B(+4.2%)
Dec 1989
$1.50B(+23.9%)
$367.90M(-5.8%)
$1.50B(+4.2%)
Sep 1989
-
$390.50M(-1.5%)
$1.43B(+5.8%)
Jun 1989
-
$396.60M(+16.5%)
$1.36B(+6.3%)
Mar 1989
-
$340.40M(+10.8%)
$1.28B(+5.7%)
Dec 1988
$1.21B(+33.1%)
$307.30M(-1.4%)
$1.21B(+6.6%)
Sep 1988
-
$311.80M(-1.4%)
$1.13B(+7.0%)
Jun 1988
-
$316.30M(+16.5%)
$1.06B(+8.3%)
Mar 1988
-
$271.40M(+16.8%)
$976.50M(+7.7%)
Dec 1987
$906.40M(+34.1%)
$232.40M(-2.2%)
$906.40M(+7.2%)
Sep 1987
-
$237.60M(+1.1%)
$845.80M(+8.3%)
Jun 1987
-
$235.10M(+16.8%)
$781.20M(+8.6%)
Mar 1987
-
$201.30M(+17.2%)
$719.30M(+6.4%)
Dec 1986
$675.70M(+25.2%)
$171.80M(-0.7%)
$675.80M(+5.9%)
Sep 1986
-
$173.00M(-0.1%)
$638.40M(+6.2%)
Jun 1986
-
$173.20M(+9.8%)
$601.40M(+6.2%)
Mar 1986
-
$157.80M(+17.4%)
$566.10M(+4.9%)
Dec 1985
$539.90M(+9.5%)
$134.40M(-1.2%)
$539.80M(+3.6%)
Sep 1985
-
$136.00M(-1.4%)
$521.00M(+3.0%)
Jun 1985
-
$137.90M(+4.9%)
$505.90M(+1.3%)
Mar 1985
-
$131.50M(+13.8%)
$499.40M(+1.3%)
Dec 1984
$493.00M
$115.60M(-4.4%)
$493.00M(+30.6%)
Sep 1984
-
$120.90M(-8.0%)
$377.40M(+47.1%)
Jun 1984
-
$131.40M(+5.0%)
$256.50M(+105.0%)
Mar 1984
-
$125.10M
$125.10M

FAQ

  • What is Merck & Co annual net profit?
  • What is the all time high annual net income for Merck & Co?
  • What is Merck & Co annual net income year-on-year change?
  • What is Merck & Co quarterly net profit?
  • What is the all time high quarterly net income for Merck & Co?
  • What is Merck & Co quarterly net income year-on-year change?
  • What is Merck & Co TTM net profit?
  • What is the all time high TTM net income for Merck & Co?
  • What is Merck & Co TTM net income year-on-year change?

What is Merck & Co annual net profit?

The current annual net income of MRK is $17.12B

What is the all time high annual net income for Merck & Co?

Merck & Co all-time high annual net profit is $17.12B

What is Merck & Co annual net income year-on-year change?

Over the past year, MRK annual net profit has changed by +$16.75B (+4589.59%)

What is Merck & Co quarterly net profit?

The current quarterly net income of MRK is $3.74B

What is the all time high quarterly net income for Merck & Co?

Merck & Co all-time high quarterly net profit is $7.32B

What is Merck & Co quarterly net income year-on-year change?

Over the past year, MRK quarterly net profit has changed by $0.00 (0.00%)

What is Merck & Co TTM net profit?

The current TTM net income of MRK is $17.12B

What is the all time high TTM net income for Merck & Co?

Merck & Co all-time high TTM net profit is $17.12B

What is Merck & Co TTM net income year-on-year change?

Over the past year, MRK TTM net profit has changed by $0.00 (0.00%)
On this page